PKR involvement in Alzheimer's disease.

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Alzheimer's disease (AD) pathology involves amyloid-beta (Aβ) accumulation, neurofibrillary tangles, and neuronal loss.
• The amyloid cascade hypothesis suggests Aβ oligomers trigger neurotoxicity, kinase activation, tau phosphorylation, and neurodegeneration.
• Kinase activation is linked to neuronal death, free radical production, and neuroinflammation.

Purpose of the Study:

• To review the role of eukaryotic initiation factor 2α kinase 2 (PKR) in Alzheimer's disease.
• To highlight the link between PKR, abnormal brain metabolism, and AD lesions.
• To explore PKR inhibition as a potential neuroprotective strategy for AD.

Main Methods:

• Literature review of studies investigating PKR in Alzheimer's disease.
• Analysis of PKR's involvement in molecular pathways related to AD.
• Examination of PKR's impact on Aβ synthesis and inflammatory responses.

Main Results:

• PKR is a pro-apoptotic enzyme implicated in AD brain lesions and memory impairment.
• PKR accumulates in degenerating neurons, is activated by Aβ1-42, and may induce BACE 1.
• Elevated PKR in cerebrospinal fluid correlates with AD and mild cognitive impairment, promoting inflammation (TNFα, IL1-β) and down-regulating memory consolidation.

Conclusions:

• PKR signaling plays a detrimental role in Alzheimer's disease.
• PKR inhibition presents a potential neuroprotective strategy.
• Targeting PKR could reduce neuronal demise and alleviate cognitive decline in AD patients.